Search

Author/Creator Cross, W

1. LBA5_PRRadiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE. (23rd October 2018)

Authors:
Parker, C C; James, N D; Brawley, C; Clarke, N W; Attard, G; Chowdhury, S; Cross, W; Dearnaley, D P; Gilson, C E; Jones, R; Mason, M D; Millman, R; Gillessen, S; Eswar, C; Gale, J; Lester, J; Sheehan, D; Tran, A; Parmar, M K; Sydes, M R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. (26th February 2018)

Authors:
Sydes, M R; Spears, M R; Mason, M D; Clarke, N W; Dearnaley, D P; de Bono, J S; Attard, G; Chowdhury, S; Cross, W; Gillessen, S; Malik, Z I; Jones, R; Parker, C C; Ritchie, A W S; Russell, J M; Millman, R; Matheson, D; Amos, C; Gilson, C; Birtle, A
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. LBA4Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer. (23rd October 2018)

Authors:
Hoyle, A P; Ali, S A; James, N D; Parker, C C; Cook, A D; Attard, G; Chowdhury, S; Cross, W; Dearnaley, D P; de Bono, J S; Gilson, C E; Gillessen, S; Jones, R; Matheson, D; Mason, M D; Ritchie, A; Russell, M; Parmar, M K; Sydes, M R; Clarke, N W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. (27th September 2019)

Authors:
Clarke, N W; Ali, A; Ingleby, F C; Hoyle, A; Amos, C L; Attard, G; Brawley, C D; Calvert, J; Chowdhury, S; Cook, A; Cross, W; Dearnaley, D P; Douis, H; Gilbert, D; Gillessen, S; Jones, R J; Langley, R E; MacNair, A; Malik, Z; Mason, M D
Journal:
Annals of oncology
Issue:
Volume 30:Number 12(2019)
Page Start:
1992
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup. (November 2016)

Authors:
Gnanapragasam, VJ; Hori, S; Johnston, T; Smith, D; Muir, K; Alonzi, R; Winkler, M; Warren, A; Staffurth, J; Khoo, V; Tree, A; Macneill, A; McMenemin, R; Mason, M; Cathcart, P; de Souza, N; Sooriakumaran, P; Weston, R; Wylie, J; Hall, E
Journal:
Journal of clinical urology
Issue:
Volume 9:Number 6(2016:Nov.)
Page Start:
369
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗